Vol 12, No 5 (2016)

Date published: 2017-03-08

Table of Contents

open access

Current literature review

Maciej Kawecki

DOI: 10.5603/OCP.2016.0014
Oncol Clin Pract 2016;12(5):197-200.
ORIGINAL ARTICLES

The activity of pembrolizumab in therapy of pretreated metastatic melanomas — two centres’ experience

Paweł Rogala, Joanna Stępniak, Tomasz Świtaj, Ewa Kalinka-Warzocha, Katarzyna Kozak, Hanna Koseła-Paterczyk, Piotr Rutkowski

Research paper

DOI: 10.5603/OCP.2016.0008
Oncol Clin Pract 2016;12(5):161-166.
REVIEW ARTICLES

Treatment of advanced ovarian cancer with bevacizumab in Poland — a chance to improve survival still missed

Paweł Blecharz, Radosław Mądry, Marek Jasiówka

Review paper

DOI: 10.5603/OCP.2016.0009
Oncol Clin Pract 2016;12(5):167-178.

Leptomeningeal metastases in breast cancer patients — current rules of diagnosis and treatment

Anna Niwińska, Michał Kunkiel

Review paper

DOI: 10.5603/OCP.2016.0010
Oncol Clin Pract 2016;12(5):179-184.
CASE REPORT

Long-term response of hepatocellular carcinoma to sorafenib in a patient with HFE-haemochromatosis

Krystyna Serkies, Ewa Pawłowska, Jacek Zieliński, Krystian Adrych, Rafał Pęksa

Case report

DOI: 10.5603/OCP.2016.0011
Oncol Clin Pract 2016;12(5):185-189.

Rectal metastases from breast invasive lobular carcinoma

Abdalla Saad Abdalla Al-Zawi

Case report

DOI: 10.5603/OCP.2016.0012
Oncol Clin Pract 2016;12(5):190-192.
CONGRESS REPORT

ESMO 2016 Congress: Three of the most important studies in the field of immuno-oncology

Dorota Kwapisz

Congress abstract / Abstract

DOI: 10.5603/OCP.2016.0013
Oncol Clin Pract 2016;12(5):193-196.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl